The Amplify Alternative Harvest ETF seeks to track the Prime Alternative Harvest Index, a rules-based benchmark of global companies engaged in the legal cultivation, production, marketing, and distribution of cannabis and related products. The index identifies firms deriving a meaningful share of revenue from cannabis and ancillary activities, and applies a proprietary weighting methodology that caps the largest primary beneficiaries while equal-weighting secondary beneficiaries.
The fund's portfolio exposure is heavily concentrated in healthcare and consumer-defensive businesses, with the majority of underlying revenue tied to regulated cannabis operations. Geographic allocation leans toward Canada and the United States, reflecting the most mature legal markets. Top positions typically include major Canadian licensed producers such as TLRY, CRON, CGC, SNDL, and ACB, alongside US-facing names and a sizable allocation to the Amplify Seymour Cannabis ETF (CNBS).
Structurally, the fund is non-diversified and carries a net expense ratio of approximately 0.75%. Its future performance potential is tightly linked to the pace of legalization, pricing discipline within oversupplied Canadian markets, and the ability of US operators to expand profitably as federal restrictions evolve. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The cannabis sector sits at the intersection of consumer discretionary demand, healthcare-oriented products, and regulatory policy. Its macro outlook remains closely tied to interest rates and risk appetite: higher-for-longer rate environments raise financing costs for capital-intensive cultivators and weigh on the small-cap growth profile that dominates this asset class. Conversely, a more accommodative rate cycle could ease funding pressures and support a re-rating of growth-oriented holdings.
Inflation dynamics also matter, as input costs and pricing power vary across cultivation, processing, and retail segments. Broader equity market trends influence flows into thematic ETFs, while currency movements between the US dollar and Canadian dollar can affect the translated returns of the fund's substantial Canadian exposure. Ultimately, the index outlook hinges less on near-term macro data and more on the trajectory of legalization policy, industry consolidation, and the sector's shift toward sustainable free cash flow generation. From what I see, monitoring these elements through tools like Tickeron’s AI Trend Prediction Engine adds a useful layer to the analysis.
Over the long term, the cannabis investment theme rests on three structural pillars: normalization of federal policy in the United States, maturation and consolidation of global markets, and the transition of leading operators toward consistent profitability. Demographic trends favoring broader social acceptance, combined with the medical-use growth opportunity in aging populations, provide a durable demand backdrop. Market structure changes, including mergers among cultivators and the rise of capital-efficient, asset-light models, could gradually improve industry economics.
The fund's long-term outlook is also shaped by index design. Quarterly rebalancing and concentration limits can shift exposure as individual names grow or contract, meaning the portfolio's composition may evolve with industry leadership. Interest rate cycles and global investment trends toward and away from thematic, higher-risk strategies will continue to influence capital availability and valuation multiples across the sector.
In my view, incorporating systematic signals can help clarify near-term direction amid policy uncertainty. I recently ran the holdings through Tickeron’s AI Trend Prediction Engine to get a data-driven sense of potential bullish, bearish, or sideways moves over the coming weeks. It surfaces developing trends and offers historical context that complements fundamental work on regulatory catalysts and balance-sheet trends. This approach keeps the focus on observable signals rather than speculation.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
MJ saw its Momentum Indicator move below the 0 level on September 30, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned negative. In 76 of the 83 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for MJ turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 36 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
MJ moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MJ crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MJ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for MJ entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for MJ's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +3.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where MJ advanced for three days, in 189 of 212 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
MJ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category MiscellaneousSector